Age-adjusted melanoma on the rise As the U.

Age-adjusted melanoma on the rise As the U.S . Observes Skin Cancer Awareness Month in May, a written report released in the April problem of Mayo Clinic Proceedings has some sobering news for young adults: The incidence of melanoma improved eightfold among young ladies and fourfold among teenagers from 1970 through 2009. And, based on the May 11 problem of Morbidity and Mortality Weekly Record, published by the Centers for Disease Control and Prevention, age-adjusted incidence rates of melanoma have increased recently; although protecting behaviors such as for example sunscreen use, shade make use of, and wearing long clothes to the ankles have increased, sunburn prevalence remains high, with 50 % of all adults reporting at least one sunburn during the past 12 months.

We anticipate ColoPrint to end up being well received amongst doctors and sufferers for a far more personalized management of the disease. .. Agendia launches ColoPrint microarray-based 18-gene expression signature for cancer of the colon Agendia, an innovative molecular cancer diagnostics head and business in personalized medicine, today announced the start of its ColoPrint microarray-based 18-gene expression signature for predicting the chance of distant recurrence for stage II cancer of the colon patients who’ve undergone surgery. ColoPrint offers a definitive relapse risk evaluation for 100 % of all stage II patients and eliminates the gray region of indeterminate results within 70 % of patients using scientific and pathologic factors such as for example T4-stage and Microsatellite Instability status.